Associations between Brain Reserve Proxies and Clinical Progression in Alzheimer’s Disease Dementia

The purpose of this study was to investigate whether brain and cognitive reserves were associated with the clinical progression of AD dementia. We included participants with AD dementia from the Alzheimer’s Disease Neuroimaging Initiative, provided they were followed up at least once, and candidate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hyung-Jun Yoon, Seung-Gon Kim, Sang Hoon Kim, Jong Inn Woo, Eun Hyun Seo, For the Alzheimer’s Disease Neuroimaing Initiative
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/b07a259944f247c59587c34f2a77624f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b07a259944f247c59587c34f2a77624f
record_format dspace
spelling oai:doaj.org-article:b07a259944f247c59587c34f2a77624f2021-11-25T17:51:35ZAssociations between Brain Reserve Proxies and Clinical Progression in Alzheimer’s Disease Dementia10.3390/ijerph1822121591660-46011661-7827https://doaj.org/article/b07a259944f247c59587c34f2a77624f2021-11-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/22/12159https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601The purpose of this study was to investigate whether brain and cognitive reserves were associated with the clinical progression of AD dementia. We included participants with AD dementia from the Alzheimer’s Disease Neuroimaging Initiative, provided they were followed up at least once, and candidate proxies for cognitive (education for early-life reserve and Adult Reading Test for late-life reserve) or brain reserve (intracranial volume [ICV] for early-life reserve and the composite value of [<sup>18</sup>F] fluorodeoxyglucose positron emission tomography regions of interest (FDG-ROIs) for late-life reserve) were available. The final analysis included 120 participants. Cox proportional hazards model revealed that FDG-ROIs were the only significant predictor of clinical progression. Subgroup analysis revealed a significant association between FDG-ROIs and clinical progression only in the larger ICV group (HR = 0.388, <i>p</i> = 0.028, 95% CI 0.167–0.902). Our preliminary findings suggest that relatively preserved cerebral glucose metabolism might delay further clinical progression in AD dementia, particularly in the greater ICV group. In addition to ICV, cerebral glucose metabolism could play an important role as a late-life brain reserve in the process of neurodegeneration. Distinguishing between early- and late-life reserves, and considering both proxies simultaneously, would provide a wider range of factors associated with the prognosis of AD dementia.Hyung-Jun YoonSeung-Gon KimSang Hoon KimJong Inn WooEun Hyun SeoFor the Alzheimer’s Disease Neuroimaing InitiativeMDPI AGarticleAlzheimer’s diseasedementiacognitive reservebrain reserveclinical progressioncerebral glucose metabolismMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 12159, p 12159 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer’s disease
dementia
cognitive reserve
brain reserve
clinical progression
cerebral glucose metabolism
Medicine
R
spellingShingle Alzheimer’s disease
dementia
cognitive reserve
brain reserve
clinical progression
cerebral glucose metabolism
Medicine
R
Hyung-Jun Yoon
Seung-Gon Kim
Sang Hoon Kim
Jong Inn Woo
Eun Hyun Seo
For the Alzheimer’s Disease Neuroimaing Initiative
Associations between Brain Reserve Proxies and Clinical Progression in Alzheimer’s Disease Dementia
description The purpose of this study was to investigate whether brain and cognitive reserves were associated with the clinical progression of AD dementia. We included participants with AD dementia from the Alzheimer’s Disease Neuroimaging Initiative, provided they were followed up at least once, and candidate proxies for cognitive (education for early-life reserve and Adult Reading Test for late-life reserve) or brain reserve (intracranial volume [ICV] for early-life reserve and the composite value of [<sup>18</sup>F] fluorodeoxyglucose positron emission tomography regions of interest (FDG-ROIs) for late-life reserve) were available. The final analysis included 120 participants. Cox proportional hazards model revealed that FDG-ROIs were the only significant predictor of clinical progression. Subgroup analysis revealed a significant association between FDG-ROIs and clinical progression only in the larger ICV group (HR = 0.388, <i>p</i> = 0.028, 95% CI 0.167–0.902). Our preliminary findings suggest that relatively preserved cerebral glucose metabolism might delay further clinical progression in AD dementia, particularly in the greater ICV group. In addition to ICV, cerebral glucose metabolism could play an important role as a late-life brain reserve in the process of neurodegeneration. Distinguishing between early- and late-life reserves, and considering both proxies simultaneously, would provide a wider range of factors associated with the prognosis of AD dementia.
format article
author Hyung-Jun Yoon
Seung-Gon Kim
Sang Hoon Kim
Jong Inn Woo
Eun Hyun Seo
For the Alzheimer’s Disease Neuroimaing Initiative
author_facet Hyung-Jun Yoon
Seung-Gon Kim
Sang Hoon Kim
Jong Inn Woo
Eun Hyun Seo
For the Alzheimer’s Disease Neuroimaing Initiative
author_sort Hyung-Jun Yoon
title Associations between Brain Reserve Proxies and Clinical Progression in Alzheimer’s Disease Dementia
title_short Associations between Brain Reserve Proxies and Clinical Progression in Alzheimer’s Disease Dementia
title_full Associations between Brain Reserve Proxies and Clinical Progression in Alzheimer’s Disease Dementia
title_fullStr Associations between Brain Reserve Proxies and Clinical Progression in Alzheimer’s Disease Dementia
title_full_unstemmed Associations between Brain Reserve Proxies and Clinical Progression in Alzheimer’s Disease Dementia
title_sort associations between brain reserve proxies and clinical progression in alzheimer’s disease dementia
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/b07a259944f247c59587c34f2a77624f
work_keys_str_mv AT hyungjunyoon associationsbetweenbrainreserveproxiesandclinicalprogressioninalzheimersdiseasedementia
AT seunggonkim associationsbetweenbrainreserveproxiesandclinicalprogressioninalzheimersdiseasedementia
AT sanghoonkim associationsbetweenbrainreserveproxiesandclinicalprogressioninalzheimersdiseasedementia
AT jonginnwoo associationsbetweenbrainreserveproxiesandclinicalprogressioninalzheimersdiseasedementia
AT eunhyunseo associationsbetweenbrainreserveproxiesandclinicalprogressioninalzheimersdiseasedementia
AT forthealzheimersdiseaseneuroimainginitiative associationsbetweenbrainreserveproxiesandclinicalprogressioninalzheimersdiseasedementia
_version_ 1718411941213372416